Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin

類似資料

• Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial
  著者:: Jensterle, Mojca, 等
  出版事項: (2017)
• Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: Randomized control study
  著者:: JENSTERLE, MOJCA, 等
  出版事項: (2016)
• SLC6A4 5HTTLPR Polymorphism Affects Insulin Secretion in Patients with Polycystic Ovary Syndrome
  著者:: Barbara Šenk, 等
  出版事項: (2018-01-01)
• SLC6A4 5HTTLPR Polymorphism Affects Insulin Secretion in Patients with Polycystic Ovary Syndrome
  著者:: Šenk, Barbara, 等
  出版事項: (2018)
• Decreased Androgen Levels and Improved Menstrual Pattern after Angiotensin II Receptor Antagonist Telmisartan Treatment in Four Hypertensive Patients with Polycystic Ovary Syndrome: Case Series
  著者:: Jensterle, Mojca, 等
  出版事項: (2007)